You are here

ABT-072

Abbott Presents Positive Results From Phase 2 "Pilot" Study Of An Interferon-Free Combination Regimen For The Treatment Of Hepatitis C

Pharmaceutical Online

Sat, 04/21/12 - 01:03 pm

Abbott Laboratories

5 Biotech Stocks That Could Soar On New Hepatitis C Drugs

Seeking Alpha

Sat, 04/21/12 - 12:17 pm

Abbott Laboratories

Abbott Hepatitis C Therapy Works After Other Drugs Fail

Bloomberg

Wed, 04/4/12 - 11:15 am

Abbott Laboratories

Pharmasset Falls on Rival Abbott Hepatitis C Therapy Results

Reuters

Sat, 10/22/11 - 12:20 pm

Abbott Laboratories

protease inhibitors